Menu
Oncoguard® Liver Logo
  • PROVIDERS
    • Overview
    • The Oncoguard® Liver test
      • Clinical Performance
      • Scientific Rigor
      • Adding to the Workflow
      • Orders & Results
      • Insurance & Billing
    • Patient engagement program
    • About Us
    • Faqs
  • Patients
    • Liver Disease
      • Risk Factors
      • Detection & Monitoring
    • The Oncoguard® Liver Solution
      • The Oncoguard® Liver Test
      • Support
    • About Us
    • FAQs
  • EDUCATION
  • Resources
    • Ordering Information
    • Order Supplies
    • Forms
    • Specimen Collection
    • Implementation Guide
    • EpicCare® Link™
    • Advocacy
  • Contact US

Posts in: Featured

  • Featured
    From inception to practice— new insights from the development of a high-performance liquid biopsy test for the detection of early-stage HCC
  • Featured
    HCC surveillance: common goals, collective impact
  • Featured
    Evaluating an ALTernative to UltraSound: the ALTUS study for the surveillance of HCC
  • Masked nurse and older heavy set man
    Featured
    The COVID-19 pandemic reveals an opportunity to optimize the surveillance of HCC
  • Female doctor speaking to a patient
    Featured
    Hepatocellular carcinoma in the United States—HCV infection remains a threat, even as NAFLD increases
  • Illustration of two healthcare professionals examining an enlarged liver graphic with a magnifying glass, alongside a clipboard displaying a test checklist
    Featured
    Improved Surveillance Is Urgently Needed to Help Reduce the Burden of Hepatocellular Carcinoma
  • ES-OGL-Blog
    Featured
    A simple blood test may detect HCC in its early stages, potentially improving patient outcomes
  • Healthcare provider reviewing information on a tablet with a patient during an office visit
    Featured
    Hepatocellular carcinoma is 10 times more likely to develop in the setting of nonalcoholic steatohepatitis than in simple fatty liver disease
  • Healthcare provider performing a physical abdominal exam on a patient lying on an exam table
    Featured
    Chronic liver disease is often a precursor to hepatocellular carcinoma
  • Healthcare provider performing an ultrasound examination on a patient, illustrating an example of hepatocellular carcinoma surveillance
    Featured
    Early-stage hepatocellular carcinoma can be challenging to detect—it doesn’t have to be
  • Healthcare provider and patient reviewing information on a tablet
    Featured
    We can improve hepatocellular carcinoma surveillance by understanding how risk factors are changing
  • Illustration of researchers pouring liquid into test tubes and examining a large liver graphic
    Featured
    Hepatocellular carcinoma has a high mortality rate—Improved surveillance may help reduce it

Sign up to be notified when a new blog is posted

exs-lvr-icon-blog-signup
Exact Sciences Logo

Exact Sciences Corporation
5505 Endeavor Lane
Madison, WI 53719
Contact Us

Quick Links

  • About Exact Sciences
  • Licensing & Accreditations
  • Terms of Use
  • Privacy Policy
  • HIPAA Notice
  • Do Not Sell or Share My Personal Information

Follow us on

  • Facebook
  • Twitter
  • LinkedIn

Oncoguard is a registered trademark of the Abbott group of companies. Epic and EpicCare Link are trademarks of Epic Systems Corporation. All third-party marks—® and ™—are the property of their respective owners.

© 2026 Abbott. All rights reserved.